Review of studies · Supplements / medicine · 17 Nov 2026
Across 16 studies and 5,679 older adults, a higher medication burden lined up with higher odds of sarcopenia
Source: BMC Geriatrics
What the research found
A systematic review and meta-analysis was published online on 17 November 2026. Sixteen observational studies included 5,679 adults aged 60 and older. The abstract does not give a sex split. Searches ran through 31 August 2026. For polypharmacy and confirmed sarcopenia, five studies gave a pooled adjusted odds ratio of 2.25 (95 percent CI 1.43 to 3.55; I-squared 31.43 percent). Eight studies gave a crude odds ratio of 2.18 (1.51 to 3.16). The count of medications, as a continuous number, did not differ (mean difference 0.01, −0.62 to 0.64). Probable or possible sarcopenia had a crude odds ratio of 1.82 (1.29 to 2.56); a Hartung-Knapp interval for that three-study result was 0.86 to 3.84 and included no difference. GRADE certainty was very low for all four outcomes. Mostly cross-sectional. Not a reason to stop a medicine on your own. DOI 10.1186/s12877-026-08689-9. Not medical advice.
Evidence level: Review of studies. This is among the stronger kinds of evidence, but one study rarely settles a question.
More supplements / medicine news
- Across 64 Middle East and North Africa trials, intermediate vitamin D doses raised 25(OH)D, and higher doses added less
- In 160 adolescents with obesity, weekly tirzepatide for 72 weeks lowered BMI more than placebo
- In 130 women after menopause, date palm pollen lined up with higher sexual-function scores over two months
- In 914 Mexican adolescents, about half had vitamin D deficiency, and girls had lower levels than boys
- In 38 healthy adults, a vitamin D3 bolus lined up with uneven next-day chromatin shifts